We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2025 Volume 5 Issue 1

The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis


,
  1. Department of Clinical Oncology, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Abstract

The spread of tumors significantly worsens outcomes for individuals with gastric cancer. RNA-binding proteins (RBPs) play key roles in cancer spread, although their specific contributions to gastric cancer remain underexplored. In this work, we identified ESRP1, an epithelial-specific RBP, as a critical modulator of metastatic behavior in gastric cancer cells. Levels of ESRP1 show an inverse association with both distant and lymph node metastases in affected patients. Experiments confirmed that ESRP1 suppresses cell migration and invasion in gastric cancer models both in laboratory settings and animal studies. At the molecular level, ESRP1 facilitates alternative splicing of exon 11 in CLSTN1 pre-mRNA. The resulting shorter isoform of CLSTN1 strengthens the interaction between E-cadherin and β-catenin, while enhancing ubiquitination and subsequent degradation of β-catenin protein, ultimately restraining migratory and invasive properties of gastric cancer cells. This investigation underscores ESRP1's suppressive influence on gastric cancer spread and uncovers additional mechanistic insights. Findings suggest that ESRP1 and CLSTN1 could serve as promising targets for interventions against metastatic gastric cancer.


How to cite this article
Vancouver
Fernandez E, Moore MQ. The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis. Asian J Curr Res Clin Cancer. 2025;5(1):177-95. https://doi.org/10.51847/cZOZ2TW0T4
APA
Fernandez, E., & Moore, M. Q. (2025). The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis. Asian Journal of Current Research in Clinical Cancer, 5(1), 177-195. https://doi.org/10.51847/cZOZ2TW0T4
Articles
Long-Term Survival Outcomes of Colorectal Cancer Survivors: An In-Depth Exploration
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Zhaobei Cai
Theoretical Model of Thiophene and Its Derivatives Interaction with BRCA-1
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Lauro FigueroaValverde
Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 1, 2022 | Lauro FigueroaValverde
Tolerability of Chemoradiotherapy in Geriatric Patients with Pancreatic Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | İrem Sarıcanbaz
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee
Environmental Impact of the Y-Isomer of HCH: Unveiling Its Role in Cancer Formation
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 2, 2022 | Mata Uvaysovna Razhaeva

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.